In Silico Clinical Trials: Is It Possible?-Reference-Cited by-同舟云学术

In Silico Clinical Trials: Is It Possible?

Published:2023-09-14 Issue: Volume: Page:51-99
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Arsène Simon,Parès Yves,Tixier Eliott,Granjeon-Noriot Solène,Martin Bastien,Bruezière Lara,Couty Claire,Courcelles Eulalie,Kahoul Riad,Pitrat Julie,Go Natacha,Monteiro Claudio,Kleine-Schultjann Julie,Jemai Sarah,Pham Emmanuel,Boissel Jean-Pierre,Kulesza Alexander

Publisher

Springer US

Link

https://link.springer.com/content/pdf/10.1007/978-1-0716-3449-3_4

Reference175 articles.

1. Scannell JW, Blanckley A, Boldon H, Warrington B (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11:191–200. https://doi.org/10.1038/nrd3681

2. Scannell JW, Bosley J, Hickman JA et al (2022) Predictive validity in drug discovery: what it is, why it matters and how to improve it. Nat Rev Drug Discov 21:915–931. https://doi.org/10.1038/s41573-022-00552-x

3. Standing JF (2017) Understanding and applying pharmacometric modelling and simulation in clinical practice and research. Br J Clin Pharmacol 83:247–254. https://doi.org/10.1111/bcp.13119

4. Williams PJ, Ette EI (2000) The role of population pharmacokinetics in drug development in light of the Food and Drug Administration’s “Guidance for Industry: Population Pharmacokinetics”. Clin Pharmacokinet 39:385–395. https://doi.org/10.2165/00003088-200039060-00001

5. Gobburu JVS, Marroum PJ (2001) Utilisation of pharmacokinetic-pharmacodynamic modelling and simulation in regulatory decision-making. Clin Pharmacokinet 40:883–892. https://doi.org/10.2165/00003088-200140120-00001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programme;European Journal of Preventive Cardiology;2024-08-05

2. Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data;Pharmaceutics;2024-06-30

3. A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate–Severe Asthma;Advances in Therapy;2024-06-25

4. Advancing cancer drug development with mechanistic mathematical modeling: bridging the gap between theory and practice;Journal of Pharmacokinetics and Pharmacodynamics;2024-06-21

5. Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers;2024-05-23